NASDAQ · DCTH

Delcath Systems Inc.

$12.22 -$0.21 (-1.69%) 1D After hours
Charting by TradingView

Key Metrics

$429.10M
Market cap
764.89×
P/E · TTM
$90.44M
Revenue · TTM
$561.00K
Net income
EPS · TTM $0.01
Dividend yield —
Free cash flow $19.19M
Beta · 1Y 1.47
EBITDA · TTM −$1.32M
Gross margin 86.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 26
    The stock moved -11.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 26

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$429.10M
Enterprise value—
Shares outstanding34.5M
52-wk range$8.12 – $13.74
Avg volume · 20D358.7K
Net cash —
Book value / share$2.85
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNASDAQ
About Delcath Systems Inc.
IPO dateOct 19, 2000
Employees156

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E764.89
P/S4.74
P/FCF22.36
EV/EBITDA—
EV/Sales—
Graham №$0.95

Profitability

Gross 86.0%
Operating -1.8%
Net 0.6%
FCF 21.2%
ROE / ROIC 0.6% · -2.9%

Financial Health

Current ratio11.24
Quick ratio10.33
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$109.57M

Cash Flow · TTM

Operating CF $21.17M
Capex −$1.98M
Free cash flow $19.19M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

17.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$0.95 vs $12.22
Trades 12.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings